TFE3 and renal cell carcinoma: In 2016, the new WHO classification has classified t(6; 11) renal cell carcinoma and Xp11.2 translocation/TFE3 gene fusion-related renal cell carcinoma into MIT family translocation renal cell carcinoma, referred to as Xp11.2 translocation renal cell carcinoma.